Comparison of continuous and intermittent renal replacement therapy for acute renal failure
Tóm tắt
Từ khóa
Tài liệu tham khảo
Jakob SM, Frey FJ, Uehlinger DE. Does continuous renal replacement therapy favourably influence the outcome of the patients? Nephrol Dial Transplant1996; 11: 1250–1255
Mehta RL, McDonald B, Gabbai FB et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int2001; 60: 1154–1163
Suistomaa M, Kari A, Ruokonen E, Takala J. Sampling rate causes bias in APACHE II and SAPS II scores. Intensive Care Med2000; 26: 1773–1778
Atkinson AC. Optimum biased-coin designs for sequential treatment allocation with covariate information (including discussion). Stat Med1999; 18: 1741–1755
Fleiss JL, Tytun A, Ury HK. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics1980; 36: 343–346
Silvester W, Bellomo R, Cole L. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med2001; 29: 1910–1915
Gasche Y, Pascual M, Suter PM, Favre H, Chevrolet JC, Schifferli JA. Complement depletion during haemofiltration with polyacrilonitrile membranes. Nephrol Dial Transplant1996; 11: 117–119
De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol1999; 10: 846–853
Sieberth HG, Kierdorf HP. Is cytokine removal by continuous hemofiltration feasible? Kidney Int Suppl1999; 72: S79–S83
Vishwanath BS, Fux CA, Uehlinger DE, Frey BM, Franson RC, Frey FJ. Haemodialysis activates phospholipase A2 enzyme. Nephrol Dial Transplant1996; 11: 109–116
Varela MP, Kimmel PL, Phillips TM, Mishkin GJ, Lew SQ, Bosch JP. Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels. Blood Purif2001; 19: 370–379
Cianciolo G, Stefoni S, Donati G et al. Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. Nephrol Dial Transplant2001; 16: 1222–1229
Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med1981; 305: 1176–1181
Gotch FA, Levin NW, Port FK, Wolfe RA, Uehlinger DE. Clinical outcome relative to the dose of dialysis is not what you think: the fallacy of the mean. Am J Kidney Dis1997; 30: 1–15
Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet2000; 356: 26–30
Schiffl H, Lang SM, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med2002; 346: 305–310
Uchino S, Bellomo R, Ronco C. Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid–base balance. Intensive Care Med2001; 27: 1037–1043
Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med1994; 331: 1338–1342
Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet1994; 344: 570–572